Opioid and cannabinoid synergy in a mouse neuropathic pain model. Kazantzis, N P, et al.
British Journal of Pharmacology. 2016 June 9 (abstract).

Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol. Patel, R R, et al.
Brain. 2016 June 5 (abstract).

Pharmacological activation of cannabinoid 2 receptor attenuates inflammation, fibrogenesis, and promotes re-epithelialization during skin wound healing. Wang, L L, et al.
European Journal of Pharmacology. 2016 June 3 786: 128-136 (abstract).

Sativex associated with behavioral-relapse prevention strategy as treatment for cannabis dependence: a case series. Trigo, J M, et al.
Journal of Addiction Medicine. 2016 June 3 (abstract).

Marijuana use and its effects in pregnancy. Chabarria, K C, et al.
American Journal of Obstetrics and Gynecology. June 2 (abstract).

Clinical effects of synthetic cannabinoid receptor agonists compared with marijuana in emergency department patients with acute drug overdose. Zaurova, M, et al.
Journal of Medical Toxicology.2016 June 2 (abstract).

Associations between cannabis use and physical health problems in early midlife: a longitudinal comparison of persistent cannabis vs tobacco users. Meier, M H, et al.
JAMA Psychiatry. 2016 June 1 (abstract).

TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer. Elbaz, Mohamad, et al.
Oncotarget. 2016 May 27.

I use weed for my ADHD: a qualitative analysis of online forum discussions on cannabis use and ADHD. Mitchell, John T, et al.
PLOS ONE. 2016 May 26.

Ultramicronized palmitoylethanolamide in spinal cord injury neuropathic pain: a randomized, double-blind, placebo-controlled trial. Andresen, S R, et al.
Pain. 2016 May 25 (abstract).

Marijuana use is not associated with progression to advanced liver fibrosis in HIV/HCV coinfected women. Kelly, E M, et al.
Clinical and Infectious Diseases. 2016 May 25 (abstract).

Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer’s disease. Manuel, I, et al.
Neuroscience. 2016 May 17 329: 284-293 (abstract).

Influence of previous failed antispasticity therapy on the efficacy and tolerability of THC:CBD oromucosal spray for multiple sclerosis spasticity. Haupts, M, et al.
European Neurology. 2016 May 10 75(5-6): 236-243 (abstract).

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity. Patti, F, et al.
Journal of Neurology Neurosurgery and Psychiatry. 2016 May 9.

A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease. López-Sendón Moreno, J L, et al.
Journal of Neurology. 2016 May 9 (abstract).

Systemic and spinal administration of FAAH, MAGL inhibitors and dual FAAH/MAGL inhibitors produce antipruritic effect in mice. Yesilyurt, O, et al.
Archives of Dermatological Research. 2016 April 28 (abstract).

Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice. Sonego, A B, et al.
Behavioural Brain Research. 2016 April 27 309: 22-28 (abstract).

Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrheic skin and acne treatment. Oláh, A, et al.
Experimental Dermatology. 2016 April 20 (abstract).

No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO-HEPAVIH French cohort). Marcellin, F, et al.
Drug and Alcohol Review. 2016 April 13 (abstract).

Cannabidiol promotes browning in 3T3-L-1 adipocytes. Parray, H A, et al.
Molecular and Cellular Biochemistry. 2016 April 11 (abstract).

Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors. Linge, R, et al.
Neuropharmacology. 2016 April 103: 16-26 (abstract).

1169-021 / 21-Marijuana use and short-term outcomes in patients hospitalized for acute myocardial infarction. Poster presentation American College of Cardiology 2016 Scientific Sessions. 2016 April 3 (abstract).

Effects of fixed or self-titrated dosages of Savitex on cannabis withdrawal and cravings. Trigo, J M, et al.
Drug and Alcohol Dependence. 2016 April 1 161: 298-306 (abstract).

The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity. Marinelli, L, et al.
International Journal of Clinical Psychopharmacology. 2016 Mar.21 (abstract).

Cannabis and cancer: toward a new understanding. Ware, M A
Current Oncology. 2016 23 Suppl.2: S5-S6.

Why I chose to use cannabis. Perrier, L
Current Oncology. 2016 23 Suppl.2: S7.

Integrating cannabis into clinical cancer care. Abrams, D I
Current Oncology. 2016 23 Suppl.2: S8-S14.

In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma. Fischer, T, et al.
Current Oncology. 2016 23 Suppl.2: S15-S22.

Anticancer mechanisms of cannabinoids. Velasco, G, et al.
Current Oncology. 2016 23 Suppl.2: S23-32.

Use of cannabinoids in cancer care: palliative care. Aggarwal, S K
Current Oncology. 2016 23 Suppl. 2: S33-S36.

Medical cannabis associated with decreased opiate medication use in retrospective cross-sectional survey of chronic pain patients.. Boehnke, K F, et al.
Journal of Pain. 2016 Mar. 18 (abstract).

Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer’s disease. Köfalvi, A, et al.
Neuropharmacology. 2016 Mar. 11 (abstract).

Prevalence of marijuana use does not differentially increase among youth after states pass medical marijuana laws: commentary on and reanalysis of US National Survey on drug use in households data 2002-2011. Wall, M M, et al.
International Journal of Drug Policy. 2016 Mar. 29:9-13 (abstract).

Prohedonic effect of cannabidiol in a rat model of depression. Shoval, G, et al.
Neuropsychobiology. 2016 73(2): 123-129 (abstract).

Metabolic syndrome in people with a psychotic illness: is cannabis protective? Waterreus, A, et al.
Psychological Medicine. 2016 Mar.11: 1-12 (abstract).

Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats. Bakali, E, et al.
International Urogynecology Journal. 2016 Mar. 4 (abstract).

A single intrathecal or intraperitoneal injection of CB2 receptor agonist attenuates bone cancer pain and induces a time-dependent modifaction of GRK2. Lu, C, et al.
Cellular and Molecular Neurobiology. 2016 Mar.2 (abstract).

Combined treatment with morphine and ∆9-tetrahydrocannibinol (THC) in rhesus monkeys: antinociceptive tolerance and withdrawal. Gerak, L R, et al.
Journal of Pharmacology and Experimental Therapeutics. 2016 Mar. 2 (abstract).

An event-related potential study on the effects of cannabis on emotion processing. Troup, Lucy J, et al.
PLOS ONE. 2016 Feb. 29.

Use of cannabis during pregnancy and birth outcomes in an aboriginal birth cohort: a cross-sectional, population-based study. Brown, S J, et al.
BMJ Open. 2016 Feb. 23.

CBD-enriched medical cannabis for intractable pediatric epilepsy: the current Israeli experience. Tzadok, M, et al.
Seizure. 2016 Feb. 35: 41-44 (abstract).

Anti-inflammatory and osteoprotective effects of cannabinoid-2 receptor agonist Hu-308 in a rat model of lipopolysaccharide-induced periodontitis. Ossala, C A, et al.
Journal of Periodontology. 2016 Feb. 5:1-17 (abstract).

Adverse effects of cannabis on adolescent brain development: a longitudinal study. Camchong, J, et al.
Cerebral Cortex. 2016 Feb. 23 (abstract).

Health authorities data collection of THC:CBD (Sativex) oromucosal spray (L’Agenzia Italiana del farmaco web registry): figures after 1.5 years. Patti, Francesco
European Neurology. 2016 75(suppl.1): 9-12.

THC:CBD (Sativex) observational study data: evolution of resistant MS spasticity and associated symptoms. Trojano, Maria
European Neurology. 2016 75(suppl.1): 4-8.

THC:CBD (Sativex) in daily practice: available data from UK, Germany and Spain. Fernández, Oscar
European Neurology. 2016 75(suppl.1): 1-3.

Fatty acid amide hydrolase inhibitors anti-invasive and antimetastatic effects on lung cancer cells, Winkler, K, et al.
Oncotarget. 2016 Feb.22 (abstract).

Cannabis effects on driving longitudinal control with and without alcohol. Hartman, R L, et al.
Journal of Applied Toxicology. 2016 Feb. 18 (abstract).

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-y and CB2 pathways. Del Rio, C, et al.
Scientific Report. 2016 Feb.18 6:21703 (abstract).

Cannabis effects on driving longitudinal control with and without alcohol. Hartman, R L, et al.
Journal of Applied Toxicology. 2016 Feb.18 (abstract).

The effect of medicinal cannabis on pain and quality of life outcomes in chronic pain: a prospective open-label study. Haroutounian, S, et al.
Clinical Journal of Pain. 2016 Feb.17 (abstract).

Stimulation of cannabinoid CB1 receptors prevents nerve-mediated airway hyperreactivity in NGF-induced inflammation in mouse airways. Bozkurt, T E, et al.
European Journal of Pharmacology. 2016 Feb.16 (abstract).

Meta-analysis of the association between the level of cannabis use and risk of psychosis. Marconi, A, et al.
Schizophrinia Bulletin. 2016 Feb.15. (abstract).

Endocannabinoid concentrations in hair are associated with PTSD symptom severity. Wilker, S, et al.
Psychoneuroendocrinology. 2016 Feb.12 67: 198-206 (abstract).

Cannabis and psychosis: a critical overview of the relationship. Ksir, C, et al.
Current Psychiatry Reports. 2016 Feb. 18(2): 12 (abstract).

A study of the impact of cannabis on doses of discharge antipsychotic medication in individuals with schizophrenia or schizoaffective disorder. Babatope, T, et al.
Psychiatric Quarterly. 2016 Feb.13 (abstract).

Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen-induced pulmonary inflammation in mice. Frei, R B, et al.
Allergy. 2016 Feb. 6 (abstract).

Prior cannabis use is associated with outcome after intracerebral hemorrhage. Di Napoli, M, et al.
Cerebrovascular Diseases. 2016 Jan.29 41(5/6): 248-255 (abstract).

Cannabis use is associated with 3years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119). Helle, S, et al.
Schizophrenia Research. 2016 Jan. 170(1): 217-221 (abstract).

Prior cannabis use is associated with outcome after intracerebral hemorrhage. Di Napoli, M, et al.
Cerebrovascular Disease. 2016 Jan.29 41(5-6): 248-255 (abstract).

The cannabis sativa versus cannabis indica debate; an interview with Ethan Russo, MD. Piomelli, Danielle, et al.
Cannabis and Cannabinoid Research. 2016 1(1): 44-46.

Review on clinical studies with cannabis and cannabinoids 2010-2014. Kowal, Mikael A, et al.
Cannabinoids. 2016 11(special issue): 1-18.

Cannabis use, depression and anxiety: a 3-year prospective population-based study. Danielsson, Anna-Karin, et al.
Journal of Affective Disorders. 2016 193: 103-108.

Selective cannabinoid receptor-1 agonists regulate mast cell activation in an oxazolone-induced atopic dermatitis model. Nam, Gaewon et al.
Annals of Dermatology. 2016 28(1): 22-29.

Medicinal Cannabis: in vitro validation of vaporizers for the smoke-free inhalation of cannabis. Lanz, Christian et al.
PLOS ONE. 2016 January.

Impact of adolescent marijuana use on intelligence: results from two longitudinal twin studies. Jackson, N J, et al.
Proceedings of the National Academy of Sciences U S A. 2016 Jan. 19 (abstract).

Evaluating Sativex in neuropathic pain management; a clinical and neurophysiological assessment in multiple sclerosis.Russo, Margherita, et al.
Pain Medicine. 2016 January 13.

Safety and efficacy of medical cannabis oil for behavioral and psychological symptoms of dementia: an-open label, add-on, pilot study. Shelef, A, et al.
Journal of Alzheimers Disease. 2016 Jan.12 (abstract).

Effects of medical marijuana on migraine headache frequency in an adult population. Rhyne, D N, et al.
Pharmacotherapy. 2016 Jan. 9 (abstract).

Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation. Lee, W S, et al.
Molecular Medicine. 2016 Jan. 8 (abstract).

ENTER YOUR EMAIL AND GET

10% OFF

YOUR NEXT ORDER

Be the first to learn about our new product additions, events and special promotions.